|
Short-term outcomes
| | | |
|
30-day mortality
|
DLCO less than 70 % of prediction
|
17.1 (1.46–199)
|
0.024
|
|
90-day mortality
|
DLCO less than 70 % of prediction
|
8.47 (1.11–64.6)
|
0.039
|
|
Complication rate
|
Male gender
|
7.80 (3.10–19.6)
|
<0.001
|
| |
DLCO less than 70 % of prediction
|
3.51 (1.03–12.0)
|
0.045
|
|
Hospital stay
|
Open thoracotomy
|
6.75 (2.41–11.1)
|
0.003
|
| |
DLCO less than 70 % of prediction
|
8.64 (1.88–15.4)
|
0.013
|
|
Long-term outcomes
| | | |
|
5-year overall survival
|
Squamous cell carcinoma
|
3.18 (1.56–6.48)
|
0.001
|
| |
DLCO less than 70 % of prediction
|
2.37 (1.10–5.14)
|
0.028
|
|
5-year disease-free survival
|
Male gender
|
2.57 (1.29–5.09)
|
0.007
|
| |
DLCO less than 70 % of prediction
|
2.07 (1.07–4.00)
|
0.030
|
|
Recurrence rate within 2 years
|
Stage IB
|
1.7 (1.04–2.75)
|
0.035
|
